Glenmark Pharma Ltd has announced that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL)...
Aurobindo Pharma Ltd on Tuesday (August 26) announced that its subsidiary has received authorisation from the regulatory agency in the United Kingdom to market...